43 results match your criteria: "Louis-Pradel Cardiovascular Hospital[Affiliation]"

Diagnostic and therapeutic practice for Heart Failure with preserved ejection fraction around the world: An international survey.

Curr Probl Cardiol

December 2024

Heart Failure Department and Clinical Investigation Center Inserm1407, Louis Pradel Cardiovascular Hospital, Hospices Civils de Lyon, Claude Bernard University, Lyon, France.

Article Synopsis
  • A survey was conducted among physicians globally to evaluate the real-world practices for diagnosing and treating heart failure with preserved ejection fraction (HFpEF), highlighting a knowledge gap in clinical implementation.
  • 1,460 physicians from 95 countries participated, primarily cardiologists, with most using a 50% ejection fraction cut-off for HFpEF diagnosis; however, only 47.2% utilized formal diagnostic scores.
  • The results showed that while natriuretic peptides were commonly used (87.4%), SGLT2 inhibitors led as the preferred first treatment (54.4%), indicating a need for better education on HFpEF management.
View Article and Find Full Text PDF

Background And Aims: Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient subsets who might benefit from the surgery.

Methods: In TRIGISTRY, an international cohort study of consecutive patients with severe isolated functional tricuspid regurgitation (33 centres, 10 countries), survival rates up to 10 years were compared between patients who underwent isolated tricuspid valve surgery (repair or replacement) and those conservatively managed, overall and according to TRI-SCORE category (low: ≤3, intermediate: 4-5, and high: ≥6).

View Article and Find Full Text PDF

Left Ventricular Assist Device as a Bridge-to-Recovery Strategy in Alcoholic Cardiomyopathy: A Case Series.

Can J Cardiol

August 2024

Université de Lorraine, INSERM 1433, Centre d'Investigations Cliniques Plurithématique, CHRU de Nancy, France; INI-CRCT, F-CRIN Network, Nancy, France; REICATRA, Université de Lorraine, Vandœuvre-lès-Nancy, France. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • * It found that patients with mild residual TR had an 85% survival rate, while those with moderate and severe TR had significantly lower rates of 70% and 44%, respectively.
  • * The research emphasizes the need for a more detailed classification of TR severity to better predict patient outcomes and highlights the goal of achieving at least mild to moderate residual TR for successful interventions.
View Article and Find Full Text PDF

Background And Aims: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of primary prevention ICDs and survival free from sustained ventricular arrhythmia (VA) in ARVC.

Methods: This was a retrospective analysis of ARVC patients without prior VA enrolled in clinical registries from 11 countries throughout Europe and North America.

View Article and Find Full Text PDF

Background And Aims: Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management according to a TR clinical stage as assessed using the TRI-SCORE.

Methods: A total of 2,413 patients with severe isolated functional TR were enrolled in TRIGISTRY (1217 conservatively managed, 551 isolated tricuspid valve surgery, and 645 transcatheter valve repair).

View Article and Find Full Text PDF

The key data from the 2022 European Thyroid Association congress: Toward personalized treatment of Graves' orbitopathy.

Ann Endocrinol (Paris)

December 2023

Department of Endocrinology and Metabolic Diseases, Cardiovascular and Metabolic Unit, CHU Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France. Electronic address:

View Article and Find Full Text PDF

Purpose Of Review: Chronic kidney disease (CKD) is highly prevalent in patients with heart failure and reduced ejection fraction (HFrEF), representing a major factor of adverse outcomes. In clinical practice, it is one of the main reasons for not initiating, not titrating, and even withdrawing efficient heart failure drug therapies in patients.

Recent Findings: Despite limited data, studies show that HFrEF therapies maintain their benefits on cardiovascular outcomes in patients with CKD.

View Article and Find Full Text PDF
Article Synopsis
  • Recent guidelines suggest starting four key heart failure (HF) medications for patients with reduced ejection fraction (HFrEF) at once, but there's uncertainty about how cardiologists view this approach compared to HF specialists.
  • A survey with 615 cardiologists globally revealed that most prefer a traditional sequential treatment method, starting with ACE inhibitors or other recommended therapies.
  • Although many agree that beginning all four medications during initial hospitalization is doable, there's still a preference for the classic approach, indicating a need for research to alter treatment practices.
View Article and Find Full Text PDF

Background: Studies suggest that performing an electrophysiological study (EPS) may be useful to identify patients with new-onset left bundle branch block (LBBB) post-TAVR at risk of atrioventricular block. However, tools to optimize the yield of such strategy are needed. We therefore aimed to investigate whether 12-lead ECG changes post-TAVR may help identify patients with abnormal EPS findings.

View Article and Find Full Text PDF

Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes ventricular arrhythmias (VAs) and sudden cardiac death (SCD). In 2019, a risk prediction model that estimates the 5-year risk of incident VAs in ARVC was developed (ARVCrisk.com).

View Article and Find Full Text PDF

Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia.

Metabolites

March 2022

INSERM, Laboratory for Vascular Translational Science (LVTS), F-75018 Paris, France.

Article Synopsis
  • Autosomal Dominant Hypercholesterolemia (ADH) is a genetic condition linked to mutations in specific genes, and the study focused on identifying new candidate genes in a French family with varying ADH risk.
  • Researchers used advanced genetic techniques to find multiple mutations in known and unknown genes, discovering a set of variants connected with the ADH trait among patients.
  • Despite identifying several genetic variants, the findings indicate that no single variant causes elevated LDL cholesterol; rather, a combination of these variants seems necessary to express the ADH phenotype.
View Article and Find Full Text PDF

Background: The diagnosis of inflammatory cardiomyopathy remains challenging in cases presenting with arrhythmia as sole manifestation. An early diagnosis is critical as it may prevent life-threatening complications such as sudden cardiac death and atrioventricular block (AVB). The diagnostic workup of suspected cases includes multimodality imaging that requires an adequate interpretation in order to limit the risk of overdiagnosis.

View Article and Find Full Text PDF

Aims: Isolated tricuspid valve surgery (ITVS) is considered to be a high-risk procedure, but in-hospital mortality is markedly variable. This study sought to develop a dedicated risk score model to predict the outcome of patients after ITVS for severe tricuspid regurgitation (TR).

Methods And Results: All consecutive adult patients who underwent ITVS for severe non-congenital TR at 12 French centres between 2007 and 2017 were included.

View Article and Find Full Text PDF

Atrial flutter catheter ablation in adult congenital heart diseases.

Indian Pacing Electrophysiol J

June 2021

Marie Lannelongue Hospital, Department of Pediatric Cardiology and Congenital Heart Diseases, Centre de Référence Cardiopathies Congénitales Complexes M3C, Le Plessis-Robinson, France; Department of Pediatric Cardiology and Congenital Heart Diseases, Pasteur Clinic, Toulouse, France.

The important increase in life expectancy of adult patients with congenital heart disease (ACHD) has generated new challenges, including arrhythmias that represent one of the main late complications. Reentrant atrial arrhythmias are by far the main mechanism encountered, and catheter ablation has been now presented as a first-line therapy in this patient population. The number of procedures is expected to continuously increase year after year.

View Article and Find Full Text PDF

Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.

Eur J Endocrinol

July 2021

Department of Diabetology, Metabolic Diseases and Nutrition, Toulouse University Hospital, Institute of Metabolic and Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.

Article Synopsis
  • The study examined sex differences in severe outcomes of COVID-19 among adults with diabetes, analyzing data from 2,380 hospitalized patients.
  • Findings revealed that females had a lower risk of invasive mechanical ventilation, death, and ICU admission compared to males, although this female advantage was less evident in overall in-hospital mortality.
  • The research highlighted specific predictors of death linked to sex, emphasizing the need for tailored COVID-19 management strategies based on biological differences.
View Article and Find Full Text PDF

Background: Na1.5, which is encoded by the gene, is the predominant voltage-gated Na channel in the heart. Several mutations of this gene have been identified and reported to be involved in several cardiac rhythm disorders, including type 3 long QT interval syndrome, that can cause sudden cardiac death.

View Article and Find Full Text PDF

Sex-Related Differences in Cardiac Channelopathies: Implications for Clinical Practice.

Circulation

February 2021

Heart Rhythm Services, Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, Canada (L.Y., A.D.K.).

Sex-related differences in prevalence, clinical presentation, and outcome of cardiac channelopathies are increasingly recognized, despite their autosomal transmission and hence equal genetic predisposition among sexes. In congenital long-QT syndrome, adult women carry a greater risk for Torsades de pointes and sudden cardiac death than do men. In contrast, Brugada syndrome is observed predominantly in adult men, with a considerably higher risk of arrhythmic sudden cardiac death in adult men than in women.

View Article and Find Full Text PDF

Aims: The aim of this study was to identify determinants of in-hospital and mid-term outcomes after isolated tricuspid valve surgery (ITVS) and more specifically the impact of tricuspid regurgitation (TR) mechanism and clinical presentation.

Methods And Results: Among 5661 consecutive adult patients who underwent a tricuspid valve (TV) surgery at 12 French tertiary centres in 2007-2017 collected from a mandatory administrative database, we identified 466 patients (8% of all tricuspid surgeries) who underwent an ITVS. Most patients presented with advanced disease [47% in New York Heart Association (NYHA) III/IV, 57% with right-sided heart failure (HF) signs].

View Article and Find Full Text PDF

Surface Electrocardiogram Analysis to Improve Risk Stratification for Ventricular Fibrillation in Brugada Syndrome.

Heart Lung Circ

February 2021

Arrhythmias Unit, National Reference Center for Inherited Arrhythmias of Lyon, Louis Pradel Cardiovascular Hospital, Hospices Civils de Lyon, Lyon, France; University of Lyon, France. Electronic address:

View Article and Find Full Text PDF